Advanced Tumor Organoid & CAF Co-culture Service to Accelerate...

adicionou um novo artigo Health

2025-10-23 02:09:44 -

Advanced Tumor Organoid & CAF Co-culture Service to Accelerate Cancer Research

CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, has announced the launch of its new Tumor Organoid & CAF Co-culture services to provide researchers with a more physiologically relevant in vitro tumor model, enabling a deeper understanding of tumor-stromal interactions and the development of more effective cancer therapies. Although...

0 Comentários 0 Compartilhamentos 25 Visualizações 0 Anterior